查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1765310

全球全EXOME定序市场

Whole Exome Sequencing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

至2030年，全球全外EXOME定序市场规模将达74亿美元

全球全EXOME定序市场规模预计在2024年为24亿美元，预计到2030年将达到74亿美元，2024年至2030年的复合年增长率为20.2%。报告分析的细分市场之一——定序系统——预计将以21.3%的复合年增长率成长，到分析期结束时将达到41亿美元。套件细分市场在分析期间的复合年增长率预计为18.3%。

美国市场规模估计为 6.773 亿美元，中国市场预计复合年增长率为 18.8%

预计2024年，美国EXOME定序市场规模将达6.773亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到11亿美元，在2024-2030年的分析期间内，复合年增长率为18.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为18.5%和17.1%。在欧洲，预计德国市场的复合年增长率约为14.3%。

全球全外EXOME定序市场—主要趋势与驱动因素摘要

是什么推动了基因组研究中全EXOME定序的应用？

全EXOME定序 (WES) 因其能够全面洞察基因组的蛋白质转录区（即EXOME）而在基因组研究和临床诊断中的重要性日益凸显。这种方法使研究人员能够识别与疾病相关的遗传变异，包括罕见遗传疾病、癌症和神经系统疾病，使其成为精准医疗的有力工具。对个人化医疗的日益关注和遗传患者病率的上升推动了 WES 在临床和研究环境中的应用。与全基因组定序相比，WES 提供了一种经济有效的EXOME研究方法，在了解疾病的遗传基础和开发标靶治疗具有显着优势。

技术进步如何增强全EXOME定序？

次世代定序仪(NGS) 和生物资讯学技术的进步显着提高了全EXOME定序的效率、准确性和成本效益。高通量定序平台的开发、标靶富集技术的改进以及文库製备方法的最佳化，使得EXOME定序速度更快、更准确。生物资讯工具和软体的创新改进了数据分析和解读，使研究人员能够更准确地识别临床相关的遗传变异。此外，人工智慧 (AI) 和机器学习 (ML) 在基因组数据分析中的融合，使得预测疾病风险、治疗效果和患者预后成为可能，进一步扩展了全外显子组在临床诊断和精准医疗中的应用。

整个EXOME定序市场面临哪些挑战与机会？

全EXOME定序市场面临许多挑战，包括高成本、对生物资讯学专业知识的需求以及基因资料隐私方面的伦理担忧。此外，基因变异的解读仍然是一项重大挑战，因为许多检测到的变异可能具有不确定或未知的临床意义。然而，这些挑战也为成长和创新提供了机会。开发更具成本效益和可扩展性的定序平台以及使用者友好的生物资讯学工具，可以降低应用门槛，并扩大全外显子定序 (WES) 在临床环境中的应用。人们对罕见疾病研究、癌症基因组学和个人化医疗的日益关注，为WES作为识别可操作基因变异的关键工具提供了新的成长机会。此外，协作研究网路和基因组资料库的兴起，推动了对能够与现有医疗保健和研究基础设施整合的强大、可互通的定序解决方案的需求。

是什么推动了整个EXOME定序市场的成长？

整个EXOME定序市场的成长受到多种因素的推动，包括对个人化医疗的日益关注、遗传病患病率的上升以及次世代定序仪和生物资讯学的技术进步。需要全面的基因组学见解来识别致病突变并开发标靶治疗，这极大地推动了临床和研究环境中对 WES 的市场需求。高通量测序、靶向序列捕获和人工智慧主导的数据分析的技术创新使 WES 更加高效、准确和具有成本效益，从而使更广泛的医疗保健提供者和研究人员更容易获得它。随着相关人员寻求强大的基因组工具来进行疾病诊断、风险评估和治疗开发，精准医疗计划的不断发展以及对罕见疾病研究和肿瘤学的日益关注也在推动市场发展。

部分

产品（系统、套件、服务）；应用（诊断、药物发现与开发、个人化医疗、其他应用）

受访公司范例

  • Agilent Technologies, Inc.
  • Ambry Genetics
  • BGI Europe
  • Eurofins Genomics GmbH
  • GENEWIZ, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • Roche Nimblegen, Inc.
  • Sengenics
  • Thermo Fisher Scientific, Inc.

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP15631

Global Whole Exome Sequencing Market to Reach US$7.4 Billion by 2030

The global market for Whole Exome Sequencing estimated at US$2.4 Billion in the year 2024, is expected to reach US$7.4 Billion by 2030, growing at a CAGR of 20.2% over the analysis period 2024-2030. Systems, one of the segments analyzed in the report, is expected to record a 21.3% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Kits segment is estimated at 18.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$677.3 Million While China is Forecast to Grow at 18.8% CAGR

The Whole Exome Sequencing market in the U.S. is estimated at US$677.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 18.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.5% and 17.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.3% CAGR.

Global Whole Exome Sequencing Market - Key Trends & Drivers Summarized

What Is Driving the Adoption of Whole Exome Sequencing in Genomic Research?

Whole exome sequencing (WES) is rapidly gaining importance in genomic research and clinical diagnostics due to its ability to provide comprehensive insights into the protein-coding regions of the genome, known as exomes. This method enables researchers to identify genetic variants associated with diseases, including rare genetic disorders, cancers, and neurological conditions, making it a powerful tool for precision medicine. The increasing focus on personalized medicine and the rising prevalence of genetic diseases are driving the adoption of WES in clinical and research settings. Compared to whole-genome sequencing, WES offers a cost-effective approach to studying the exome, providing significant advantages in understanding the genetic basis of diseases and developing targeted therapies.

How Are Technological Advancements Enhancing Whole Exome Sequencing?

Technological advancements in next-generation sequencing (NGS) and bioinformatics are significantly enhancing the efficiency, accuracy, and cost-effectiveness of whole exome sequencing. The development of high-throughput sequencing platforms, improved target enrichment techniques, and optimized library preparation methods are enabling faster and more accurate sequencing of the exome. Innovations in bioinformatics tools and software are improving data analysis and interpretation, allowing researchers to identify clinically relevant genetic variants with greater precision. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) in genomic data analysis is enabling the prediction of disease risk, treatment response, and patient outcomes, further expanding the application of WES in clinical diagnostics and precision medicine.

What Are the Challenges and Opportunities in the Whole Exome Sequencing Market?

The whole exome sequencing market faces several challenges, including the high cost of sequencing, the need for specialized bioinformatics expertise, and ethical concerns related to genetic data privacy. Additionally, the interpretation of genetic variants remains a significant challenge, as many detected variants may have uncertain or unknown clinical significance. However, these challenges also present opportunities for growth and innovation. The development of more cost-effective and scalable sequencing platforms, along with user-friendly bioinformatics tools, can help lower the barriers to adoption and expand the use of WES in clinical practice. The increasing emphasis on rare disease research, cancer genomics, and personalized medicine is creating new growth opportunities for WES as a critical tool for identifying actionable genetic variants. Moreover, the rise of collaborative research networks and genomic databases is driving the need for robust and interoperable sequencing solutions that can integrate with existing healthcare and research infrastructures.

What Is Driving the Growth of the Whole Exome Sequencing Market?

The growth in the Whole Exome Sequencing market is driven by several factors, including the increasing focus on personalized medicine, rising prevalence of genetic disorders, and technological advancements in next-generation sequencing and bioinformatics. The need for comprehensive genomic insights to identify disease-causing variants and develop targeted therapies is significantly boosting market demand for WES in clinical and research settings. Technological innovations in high-throughput sequencing, target enrichment, and AI-driven data analysis are enhancing the efficiency, accuracy, and cost-effectiveness of WES, making it more accessible to a broader range of healthcare providers and researchers. The expansion of precision medicine initiatives, coupled with the growing emphasis on rare disease research and oncology, is also driving market growth as stakeholders seek powerful genomic tools for disease diagnosis, risk assessment, and therapeutic development.

SCOPE OF STUDY:

The report analyzes the Whole Exome Sequencing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Systems, Kits, Services); Application (Diagnostics, Drug Discovery & Development, Personalized Medicine, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Agilent Technologies, Inc.
  • Ambry Genetics
  • BGI Europe
  • Eurofins Genomics GmbH
  • GENEWIZ, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • Roche Nimblegen, Inc.
  • Sengenics
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Whole Exome Sequencing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Genetic Research Propel the Use of Whole Exome Sequencing
    • Rising Prevalence of Genetic Disorders Amplifies Demand for Whole Exome Sequencing
    • Cost Reduction in Sequencing Technologies Spurs Whole Exome Sequencing Adoption
    • Clinical Applications in Personalized Medicine Enhance Whole Exome Sequencing Capabilities
    • Pharmaceutical Companies Increasing Investment in Drug Discovery Supports Market Growth
    • Consumer Interest in Ancestry and Genealogy Expands Market Reach
    • Expansion of Newborn Screening Programs Drives Whole Exome Sequencing Services
    • Research and Development in Rare Diseases Bolster Use of Exome Sequencing
    • Growing Biobanking Activities Sustain Demand for Whole Exome Sequencing
    • Integration of AI and Machine Learning in Genomic Research Transforms Market Landscape
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Whole Exome Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Whole Exome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Personalized Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Personalized Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • CHINA
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 30: China Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: China 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 32: China Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: Europe 6-Year Perspective for Whole Exome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Europe 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 40: France Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: France 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 42: France Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: France 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Germany 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Italy 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Italy 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 52: UK Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: UK 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 54: UK Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: UK 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Rest of World 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Rest of World 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030

IV. COMPETITION